Opportunities to Address Barriers to Enrollment in Food is Medicine Programs: Lessons Learned From the SUPeRFOOD Trial
Top Things to Know
FIM evaluations should measure time to benefit initiation and actual benefit received, not enrollment alone.
The review suggests uniform referral and eligibility criteria, approval for both MTMs and MTGs so participants can transition as needs change, standardized benefit tiers based on nutrition needs, and simplified renewals.
Complex authorization requirements may create an additional barrier for people already managing chronic illness, mobility limitations, work or caregiving responsibilities.
Summary of Conclusion/Findings
This 'viewpoint' uses the implementation experience from the SUPeRFOOD pilot trial to examine insurance-related barriers to accessing medically tailored nutrition among 84 adults with diet-sensitive chronic conditions undergoing cardiac rehabilitation. Access varied substantially by payer: median time from randomization to FIM program enrollment was 64 days for Anthem Blue Cross Medi-Cal beneficiaries, 27 days for San Francisco Health Plan Medi-Cal beneficiaries and 21 days for participants directly referred without insurance authorization. During the 12-week study period, 83% of participants received at least one food benefit, but Anthem Blue Cross Medi-Cal beneficiaries received a median of 0 meal units compared with 14 for San Francisco Health Plan Medi-Cal beneficiaries and 14.5 for participants covered through other mechanisms. The authors attributed variation in access to nonstandardized referral and authorization processes, different eligibility criteria, separate approvals for medically tailored meals (MTMs) and medically tailored groceries (MTGs), pre-enrollment requirements, renewal burdens and benefit amounts determined by coverage rather than nutrition recommendations. Despite these barriers, participant-reported experience was favorable: 96.3% reported an excellent or good experience, 85.2% said the program met all or most of their healthy eating needs, and more than 90% reported that FIM benefits helped them manage their cardiovascular health conditions more effectively. Because these findings come from implementation experience within a single-center pilot in California, the authors caution that the barriers and proposed solutions require validation across other geographic regions, health care settings and insurers.